#ChronicIllnessVoice | Pharma / Science / Tech / Digital / AI | A mix of news, events and Resources

Many thanks for taking a look and if you enjoy the content please can you share it with your peers and colleagues.
It is purposefully designed to keep you reading for a little while as it will be a couple of months before the next edition will be published. … Read More #ChronicIllnessVoice | Pharma / Science / Tech / Digital / AI | A mix of news, events and Resources

#ChronicillnessVOICE SPECIAL EDITION ‘PHARMA’ APRIL 2019 | eyeforpharma Barcelona review

> I am a supporter of pharma community platforms, but as a patient wish there was one platform for all of them rather than insular separate ones. I believe that compiling resources and knowledge could lead to better results. Plus, it would make them easier to find.

>Being invited back to #efpbarca this year was indeed exciting and also an honour. This review that follows will give you a few insights into my week at Barcelona with eyeforpharma as a ‘Volunteer’ Patient Advocate, and as ‘Impatient Conference Steering Committee member, attending through their ‘Patient Policy’.

Hope you enjoy reading!… Read More #ChronicillnessVOICE SPECIAL EDITION ‘PHARMA’ APRIL 2019 | eyeforpharma Barcelona review

#ChronicillnessVOICE SPECIAL EDITION ‘PHARMA’ APRIL 2019 | eyeforpharma Barcelona review | Plus Newsletters & Resources

I am a supporter of pharma community platforms, but as a patient wish there was one platform for all of them rather than insular separate ones. I believe that compiling resources and knowledge could lead to better results. Plus, it would make them easier to find.

Hope you enjoy reading!… Read More #ChronicillnessVOICE SPECIAL EDITION ‘PHARMA’ APRIL 2019 | eyeforpharma Barcelona review | Plus Newsletters & Resources

BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Top Marketing News

How molecular biomarkers are transforming cancer treatment

AbbVie goes 3-0 in delaying Humira rivals

Drug lobby aims to shake up how medicines are paid for

Where does J&J’s new drug fit in the crowded HIV market?
5 drugs to watch as biotechs report Q2

FDA seeks to make more drugs available over the counter

Gilenya patent decision gives MS market a reprieve… Read More BioPharma Dive: Marketing | July 18 | AbbVie delays another Humira rival | PhRMA proposes rebate shake-up

Pharma / Science / Tech / AI – A mix of News | 13 July 2018

Norovirus vaccine: Oral tablet Phase 1 clinical trial results published |  Outbreak News Today  |  PRESS RELEASE  |  13 July 2018

Ticks found in 83 counties where not previously recorded: Citizen-Scientist Study  |  Outbreak News Today  |  PRESS RELEASE  |  12 July 2018

Celebrate the 2018 Warren Alpert Foundation Prize recipients and their commitment to research | STAT: Morning Rounds  |  13 July 2018

Automated virtual reality-based psychological therapy may help reduce fear of heights  |  Lancet  | 12 July 2018

Massive genome havoc in breast cancer is revealed  |  Cold Spring Harbor Laboratory  |  12 July 2018

As new posts come in…
…others will head to archives. 

Hope you enjoy reading!… Read More Pharma / Science / Tech / AI – A mix of News | 13 July 2018

Pharma / Science / Tech / AI – News

THE 8 TH GLOBAL ORPHAN DRUG CONFERENCE AND EXPO Strategy, Regulation and Opportunity for Pharma, Biotech and Investors in Rare Diseases You can register via the link below! THE 8 TH GLOBAL ORPHAN DRUG CONFERENCE AND EXPO Strategy, Regulation and Opportunity for Pharma, Biotech and Investors in Rare Diseases Latest!  BioPharma Dive |  Newsletter | 27 March 2018 #pharma … Read More Pharma / Science / Tech / AI – News

Pharma / Science / Tech / AI – News

Latest!  BioPharma Dive |  Marketing Newsletter | 7 March 2018 biopharmadive.com | Marketing Newsletter   Latest!  BioPharma Dive |  Newsletter | 8 March 2018 #pharma  #pharmanews #clinicaltrials #patientcentricity #R&D #science biopharmadive.com BioPharma Dive |  WEEKENDER Newsletter |3 March 2018 BioPharma | WEEKENDER newsletter   About BioPharma Dive:  www.biopharmadive.com/about/ pharmaphorum Top Stories  |  3 March 2018 Headlines: Dangerous inflammation prompts worldwide withdrawal of MS drug… Read More Pharma / Science / Tech / AI – News